As a senior business executive at CDx Precision Health, Alan K. Hauser is championing valuation-led risk/reward economic decision analysis for clients in the CDx-stratified medicine sector. Being an accomplished life sciences corporate development leader and Certified Licensing Professional, Dr. Hauser has a successful track record of commercializing innovative genomics-driven drug-discovery and in-vitro diagnostics detection platforms.